Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Dose Response of Oral CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

NCT04026997 is registered in ClinicalTrials.gov with CinDome Pharma, Inc. as lead sponsor.

NCT NCT04026997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04026997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Dose Response of Oral CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
Lead sponsor
CinDome Pharma, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 11, 2019
Completion date
December 17, 2020
Enrollment
72 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis